GO:0001951 intestinal D-glucose absorption: Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001951 intestinal D-glucose absorption is defined as the uptake of D-glucose into the blood by absorption from the small intestine.
• The sodium-dependent glucose transporter SGLT1 (SLC5A1) is pivotal for active intestinal glucose absorption and for glucose-dependent incretin secretion.
• Passive and paracellular routes contribute to D-glucose absorption, especially at high luminal concentrations.
• Intestinal glucose absorption is dynamically regulated by luminal glucose sensing and by hormonal and neural signals.
• Small intestinal diseases such as celiac disease, tropical sprue, and short bowel syndrome can impair glucose absorption.
• Positron emission tomography in mice provides a quantitative in vivo readout of intestinal glucose absorption.
Description
Intestinal D-glucose absorption (GO:0001951) is the biological process by which D-glucose is taken up from the small intestinal lumen into the blood. This process is essential for postprandial glucose homeostasis and is a central node in metabolic physiology, because it determines the rate at which dietary carbohydrate enters the circulation. The process is not a simple passive leak; it involves active, sodium-dependent transport across the brush-border membrane and facilitated exit across the basolateral membrane, with additional contributions from passive and paracellular pathways under specific conditions. Researchers study GO:0001951 to understand nutrient handling in health, to dissect the pathophysiology of malabsorption, and to evaluate therapeutic strategies that modulate glucose uptake in diabetes and obesity. The molecular identity of the primary intestinal glucose transporter was established through knockout and inhibitor studies. SGLT1 (encoded by SLC5A1) is a sodium-coupled cotransporter that is pivotal for intestinal glucose absorption and for glucose-dependent incretin secretion. In mice, positron emission tomography has been used to quantify intestinal glucose absorption in vivo, providing a bridge between molecular mechanisms and whole-body physiology. Comparative studies across species, including rats and amphibians, have clarified the sodium dependence and luminal sodium homeostasis that support this process. Beyond SGLT1, passive and paracellular routes can contribute to D-glucose absorption, particularly when luminal glucose concentrations are high. This multiplicity of routes explains why glucose absorption is best understood as an integrated process rather than a single-transporter event. The sections below summarize the definition, mechanism, key genes, regulation, disease links, and research methods relevant to GO:0001951.
intestinal D-glucose absorption At A Glance
| GO ID | GO:0001951 |
|---|---|
| GO term | intestinal D-glucose absorption |
| Ontology | biological_process |
| Synonym | none |
| Major function | Uptake of D-glucose into the blood by absorption from the small intestine |
| Primary transporter | SGLT1 (SLC5A1), a sodium-dependent glucose cotransporter |
| Secondary routes | Passive and paracellular absorption at high luminal glucose |
| Physiological context | Postprandial glucose homeostasis and incretin secretion |
| Disease relevance | Small intestinal diseases and malabsorption |
What Is GO:0001951?
GO:0001951 (intestinal D-glucose absorption) is the uptake of D-glucose into the blood by absorption from the small intestine. In practical terms, it describes the movement of glucose from the intestinal lumen, across the enterocyte, and into the bloodstream, encompassing active sodium-dependent transport, facilitated diffusion, and passive or paracellular contributions depending on luminal conditions.
Why Is intestinal D-glucose absorption Important in Cell Biology?
Intestinal D-glucose absorption is the rate-limiting entry point for dietary glucose into the body and therefore directly shapes postprandial glycemia, insulin secretion, and incretin release. Because SGLT1 is pivotal for this process, its activity is a major determinant of glucose-dependent incretin secretion and whole-body glucose handling. Understanding GO:0001951 is also clinically important: impaired absorption contributes to malnutrition in small intestinal diseases, whereas excessive or dysregulated absorption is relevant to metabolic disorders.
• Defines the rate of dietary glucose entry into the bloodstream after a meal.
• SGLT1-mediated transport is pivotal for intestinal glucose absorption and incretin secretion.
• Passive and paracellular pathways become relevant at high luminal glucose concentrations.
• Intestinal glucose sensing regulates the absorptive capacity of the gut.
• Small intestinal diseases can impair glucose absorption and cause malabsorption.
• Species differences in sodium-dependent transport inform comparative physiology.
• In vivo imaging with positron emission tomography enables quantitative assessment in mice.
• The process is a target for modulating postprandial glycemia in metabolic disease.
• Luminal sodium homeostasis is coupled to glucose absorption across developmental stages.
• Human in vivo studies show that D-glucose affects intestinal permeability and passive absorption.
What Happens During intestinal D-glucose absorption?
Luminal glucose sensing and transporter recruitment
In simple terms: The gut first senses how much glucose is present and adjusts how much it absorbs.
Intestinal glucose absorption is not fixed; it is regulated by luminal glucose sensing, which adjusts the absorptive capacity of the intestine. This sensing allows the gut to match transport activity to the glucose load delivered by a meal, and it couples absorption to hormonal and neural signals that influence whole-body glucose handling.
Active sodium-dependent uptake by SGLT1
In simple terms: A sodium-powered pump on the gut surface pulls glucose into the cells.
The sodium-dependent glucose cotransporter SGLT1 (SLC5A1) is pivotal for intestinal glucose absorption. SGLT1 couples the inward movement of sodium to the uptake of D-glucose across the brush-border membrane, and loss of SGLT1 function markedly reduces glucose absorption and glucose-dependent incretin secretion. Sodium dependence of intestinal glucose absorption has been demonstrated across species, including rats and amphibians.
Facilitated exit across the basolateral membrane
In simple terms: After entering the cell, glucose exits into the blood through a different transporter.
Once inside the enterocyte, D-glucose must cross the basolateral membrane to reach the blood. This exit step is mediated by facilitated diffusion transporters, completing the transepithelial movement that defines GO:0001951. The coordinated action of apical uptake and basolateral exit maintains the concentration gradient that drives absorption.
Passive and paracellular absorption at high luminal glucose
In simple terms: When glucose is very concentrated, some of it leaks between cells.
At high luminal concentrations, passive and paracellular routes contribute to D-glucose absorption. Human in vivo studies show that D-glucose affects intestinal permeability and its own passive absorption in the small intestine. In rat duodenum-jejunum, absorption of D-glucose and water influences paracellular transport, indicating that solvent drag and junctional permeability can modulate glucose uptake.
In vivo quantification and species differences
In simple terms: Scientists can measure how much glucose the gut absorbs in living animals.
Positron emission tomography in mice has been used to determine intestinal glucose absorption in vivo, providing a quantitative physiological readout. Comparative studies show that sodium-dependent intestinal glucose absorption mechanisms and luminal sodium homeostasis vary across developmental stages, such as from tadpoles to frogs. In rats, L-glucose can also be absorbed via SGLT1, highlighting the need for careful substrate specificity controls in absorption studies.
Key Genes Involved in GO:0001951 intestinal D-glucose absorption
The genes and proteins below are the principal molecular players in intestinal D-glucose absorption (GO:0001951), spanning active transport, facilitated diffusion, junctional permeability, and hormonal regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC5A1 (SGLT1) | Sodium-dependent apical glucose cotransporter; pivotal for intestinal glucose absorption | Knockout and inhibitor studies define its role in absorption and incretin secretion |
| SLC2A2 (GLUT2) | Facilitated basolateral glucose exit | Target for studying transepithelial glucose transport |
| SLC2A5 (GLUT5) | Fructose transport; indirect relevance to glucose handling | Comparative studies of sugar absorption |
| TJP1 (ZO-1) | Tight junction scaffold protein | Paracellular permeability studies |
| OCLN (Occludin) | Tight junction component | Paracellular transport modulation |
| CLDN2 (Claudin-2) | Pore-forming tight junction protein | Paracellular glucose and water transport |
| GIP | Incretin secreted in response to glucose absorption | Glucose-dependent incretin secretion studies |
| GCG (glucagon) | Precursor of GLP-1 incretin | Incretin response to absorbed glucose |
| SLC5A1 variants | Alterations affecting transport activity | Genotype-phenotype studies of glucose absorption |
| Na+/K+-ATPase subunits | Maintain sodium gradient for SGLT1 | Sodium homeostasis studies |
| AQP (aquaporins) | Water transport coupled to glucose absorption | Paracellular and water flux studies |
| SLC26A3 | Anion exchange; luminal homeostasis | Indirect modulation of absorption |
| SLC9A3 (NHE3) | Sodium-hydrogen exchange; luminal sodium homeostasis | Sodium-coupled absorption studies |
| CFTR | Chloride secretion; luminal environment | Indirect effects on absorption |
| GCG-derived peptides | Incretin signaling | Glucose-dependent incretin secretion |
| SLC5A1 regulatory kinases | Modulate transporter trafficking | Regulation of absorption capacity |
How Is intestinal D-glucose absorption Regulated?
Intestinal D-glucose absorption is regulated at multiple levels. Luminal glucose sensing adjusts the absorptive capacity of the intestine, allowing transport to match dietary load. SGLT1 activity is pivotal for glucose-dependent incretin secretion, linking absorption to hormonal feedback. Sodium homeostasis in the lumen also influences transport efficiency, as shown across developmental stages in amphibians. In addition, paracellular permeability can be modulated by luminal glucose and water flux, providing a secondary regulatory route.
intestinal D-glucose absorption and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC5A1 (SGLT1) | Glucose-galactose malabsorption; impaired intestinal glucose uptake | SLC5A1 knockout intestinal epithelial cells and mice |
| SLC2A2 (GLUT2) | Facilitated glucose exit defects | GLUT2 knockout or knockdown enterocytes |
| TJP1/OCLN/CLDN2 | Barrier dysfunction and altered paracellular transport | Tight junction knockout or point-mutation models |
| GIP/GCG | Incretin secretion defects | Incretin reporter and knockout models |
| SLC5A1 variants | Altered absorption capacity | Knock-in of patient variants |
Small intestinal diseases and malabsorption
Glucose absorption in small intestinal diseases is impaired in conditions such as celiac disease, tropical sprue, and short bowel syndrome, contributing to malnutrition and weight loss. Assessing glucose absorption can therefore aid in evaluating the functional severity of small intestinal disease.
Metabolic disorders and incretin secretion
Because SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion, alterations in this process can influence postprandial glycemia and incretin responses relevant to diabetes and obesity. Modulating absorption is a recognized strategy for controlling postprandial glucose excursions.
Intestinal permeability and barrier function
D-glucose can affect intestinal permeability and its own passive absorption in the human small intestine, linking glucose absorption to barrier function. In rat duodenum-jejunum, glucose and water absorption influence paracellular transport, suggesting that absorption and barrier properties are interdependent.
From intestinal D-glucose absorption-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is SGLT1 required for intestinal glucose absorption? | SLC5A1 knockout mice and intestinal organoids |
| Does a patient variant alter transport activity? | Point-mutation knock-in in SLC5A1 |
| How does basolateral exit contribute to absorption? | Knock-in of tagged GLUT2 for localization studies |
| Does overexpression of SGLT1 increase absorption? | Overexpression of SLC5A1 in enterocyte lines |
| How does luminal glucose sensing regulate absorption? | Reporter and knockout models of sensing pathways |
| Can absorption be quantified in vivo? | Positron emission tomography in mice |
How to Study the intestinal D-glucose absorption Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Positron emission tomography | In vivo intestinal glucose absorption | Whole-animal physiology |
| Ussing chamber | Transepithelial glucose flux | Transporter and permeability studies |
| Permeability assays | Paracellular and passive absorption | Barrier function assessment |
| RNA-seq | Transporter gene expression | SLC5A1 and SLC2A2 expression profiling |
| Western blot / immunofluorescence | Transporter protein localization | Apical vs basolateral distribution |
| Incretin secretion assays | Glucose-dependent incretin release | GIP and GLP-1 measurements |
| Knockout and knock-in models | Causal role of transporters | Gene function studies |
In vivo absorption assays
Intestinal glucose absorption can be quantified in living animals using positron emission tomography, as demonstrated in mice. Such approaches provide a physiological readout that integrates transporter activity, blood flow, and hormonal responses.
Ussing chamber and permeability studies
Ussing chamber experiments and permeability assays measure transepithelial glucose flux and paracellular transport. Human in vivo studies have shown that D-glucose affects intestinal permeability and passive absorption, and rat duodenum-jejunum studies have linked glucose and water absorption to paracellular transport.
Transporter expression and localization
Expression and localization of SGLT1 and basolateral transporters can be assessed by RNA and protein methods. SGLT1 is pivotal for intestinal glucose absorption, so its abundance and membrane localization are key readouts.
Comparative and developmental physiology
Comparative studies across species and developmental stages reveal conserved and divergent features of sodium-dependent absorption. For example, sodium-dependent intestinal glucose absorption and luminal sodium homeostasis change across metamorphosis from tadpoles to frogs, and L-glucose absorption via SGLT1 has been documented in rats.
How CRISPR Can Be Used to Study GO:0001951 intestinal D-glucose absorption
Knockout
CRISPR knockout of SLC5A1 (SGLT1) in intestinal epithelial cells or mice can test whether the transporter is required for intestinal D-glucose absorption and glucose-dependent incretin secretion. Knockout of tight junction genes such as TJP1, OCLN, or CLDN2 can probe paracellular contributions to absorption.
Point Mutation
Point-mutation knock-in of SLC5A1 variants allows assessment of how specific residues affect sodium-coupled glucose transport and absorption capacity. Such models are useful for linking genotype to transport function in glucose-galactose malabsorption.
Knock-in
Tagged knock-in of SLC5A1 or SLC2A2 enables localization and trafficking studies in enterocytes, clarifying how apical and basolateral transporters coordinate transepithelial glucose movement. Knock-in of reporter cassettes can also track transporter expression in vivo.
Overexpression
Overexpression of SLC5A1 in intestinal cell lines can test whether increased transporter abundance raises glucose absorption and incretin secretion. Overexpression models complement knockout studies by defining sufficiency rather than necessity.
How EDITGENE Supports intestinal D-glucose absorption Research
Researchers studying intestinal D-glucose absorption-related genes often need to determine whether a candidate gene is causally involved in uptake, whether a specific variant alters transport activity, or whether increased expression is sufficient to change absorption. EDITGENE provides the CRISPR tools and models required to answer these questions with rigor.
Contact EDITGENE today to design your custom CRISPR model for intestinal D-glucose absorption research.
Frequently Asked Questions About intestinal D-glucose absorption
What is GO:0001951?
GO:0001951 is the biological process of intestinal D-glucose absorption, defined as the uptake of D-glucose into the blood by absorption from the small intestine.
What genes are involved in intestinal D-glucose absorption?
Key genes include SLC5A1 (SGLT1), which is pivotal for absorption and incretin secretion, and SLC2A2 (GLUT2) for basolateral exit, along with tight junction genes such as TJP1, OCLN, and CLDN2 that influence paracellular transport.
How is glucose absorbed in the small intestine?
Glucose is absorbed by sodium-dependent uptake via SGLT1 across the brush-border membrane, followed by facilitated exit across the basolateral membrane, with passive and paracellular contributions at high luminal concentrations.
What is the role of SGLT1 in glucose absorption?
SGLT1 (SLC5A1) is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.
Can glucose be absorbed passively?
Yes, human in vivo studies show that D-glucose affects intestinal permeability and its own passive absorption in the small intestine, and rat studies link glucose and water absorption to paracellular transport.
How is intestinal glucose absorption measured?
It can be measured in vivo by positron emission tomography in mice, by Ussing chamber flux assays, and by permeability studies.
What diseases affect intestinal glucose absorption?
Small intestinal diseases such as celiac disease, tropical sprue, and short bowel syndrome can impair glucose absorption.
Does glucose absorption change across development?
Yes, sodium-dependent intestinal glucose absorption mechanisms and luminal sodium homeostasis change across metamorphosis from tadpoles to frogs.
Is L-glucose absorbed by SGLT1?
In rats, L-glucose can be absorbed via SGLT1, which is important for substrate specificity controls in absorption studies.
How does glucose absorption relate to incretin secretion?
SGLT1 is pivotal for glucose-dependent incretin secretion, linking absorption to hormonal responses.
Conclusion
GO:0001951 intestinal D-glucose absorption is a central physiological process that determines how dietary glucose enters the bloodstream. It depends primarily on the sodium-coupled transporter SGLT1, with contributions from basolateral facilitated diffusion and passive or paracellular routes. The process is regulated by luminal glucose sensing and is linked to incretin secretion and small intestinal disease. Researchers can interrogate this process using in vivo imaging, permeability assays, transporter expression profiling, and CRISPR-based knockout, point-mutation, knock-in, and overexpression models. EDITGENE provides these models and bioinformatics services to support rigorous, publication-ready studies of intestinal D-glucose absorption.
References
- 1. Kishida K et al.. 2025. Intestinal Absorption of L-Glucose via Sodium/Glucose Cotransporter 1 (Sglt1) in Rats.. J Nutr Sci Vitaminol (Tokyo) 71(6):564-567 PMID: 41485972
- 2. Sala-Rabanal M et al.. 2018. Intestinal absorption of glucose in mice as determined by positron emission tomography.. J Physiol 596(13):2473-2489 PMID: 29707805
- 3. Ishizuka N et al.. 2023. Na(+)-dependent intestinal glucose absorption mechanisms and its luminal Na(+) homeostasis across metamorphosis from tadpoles to frogs.. Am J Physiol Regul Integr Comp Physiol 324(5):R645-R655 PMID: 36939209
- 4. Thazhath SS et al.. 2014. Glucose absorption in small intestinal diseases.. Expert Rev Gastroenterol Hepatol 8(3):301-12 PMID: 24502537
- 5. Dyer J et al.. 2007. Intestinal glucose sensing and regulation of intestinal glucose absorption.. Biochem Soc Trans 35(Pt 5):1191-4 PMID: 17956309
- 6. Gorboulev V et al.. 2012. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.. Diabetes 61(1):187-96 PMID: 22124465
- 7. Fine KD et al.. 1993. Effect of D-glucose on intestinal permeability and its passive absorption in human small intestine in vivo.. Gastroenterology 105(4):1117-25 PMID: 8405857
- 8. O'Rourke M et al.. 1995. Effect of absorption of D-glucose and water on paracellular transport in rat duodenum-jejunum.. Am J Med Sci 309(3):146-51 PMID: 7879819
